glp 1 drugs How GLP-1 medications are transforming diabetes and weight loss treatment Exploring the Neurological Questions Surrounding

Who Are the Leading GLP-1 Drug Manufacturers

Conclusions In conclusion, YM selectively enhances GLP-1 gene expression and plasma levels through mechanisms likely mediated by gut microbiota

A study published in August 2024 found a higher risk of NAION among patients prescribed semaglutide compared to individuals using non-GLP-1 receptor agonist medications, with 17 cases occurring in the semaglutide group versus six in the comparison group

Beyond weight loss, data are emerging for the undeniable benefits on a wide variety of maladies, including cardiovascular disease (155157), obstructive sleep apnea (158), MASLD (159), addiction disorders (160, 161), and dementia (162)

However, Vash says, that's a very rare side effect. And if youve heard that GLP-1s can increase your risk of thyroid cancer, you dont necessarily need to be alarmed